Figure 3 | Modern Pathology

Figure 3

From: β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

Figure 3

β-Catenin expression in invasive breast carcinomas according to the molecular subtypes. β-Catenin membranous and nuclear expression using 14/β-catenin (a, b) or 17C2 (c, d) clones in the cohort after exclusion of lobular carcinomas (n=182/183, respectively) according to the molecular subtypes of breast cancer as defined by the immunohistochemical surrogate described by Nielsen et al.34 *χ2 test.

Back to article page